SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001232953-20-000002
Filing Date
2020-03-23
Accepted
2020-03-23 17:53:01
Documents
1
Period of Report
2020-03-19

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4/A  
1 PRIMARY DOCUMENT primary_doc.xml 4/A 5790
  Complete submission text file 0001232953-20-000002.txt   7398
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
VERMILLION, INC. (Issuer) CIK: 0000926617 (see all company filings)

IRS No.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 2751 CENTERVILLE RD STE 400 WILMINGTON DE 19808
Business Address
COCOZZA NANCY G (Reporting) CIK: 0001232953 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-34810 | Film No.: 20735967